ストックスクリーナーアプリを入手
2.37
2.47%
-0.06
アフターアワーズ：
2.40
0.03
+1.27%
前日終値:
$2.43
開ける：
$2.4
24時間の取引高:
46,668
Relative Volume:
0.13
時価総額：
$3.42M
収益：
-
当期純損益:
$-11.96M
株価収益率:
-0.0283
EPS:
-83.7383
ネットキャッシュフロー:
$-10.19M
1週間 パフォーマンス:
-10.57%
1か月 パフォーマンス:
-4.82%
6か月 パフォーマンス:
-95.61%
1年 パフォーマンス:
-98.74%
1日の値動き範囲:
$2.325
$2.56
1週間の範囲:
$2.325
$2.73
52週間の値動き範囲:
$2.10
$311.36
Gri Bio Inc Stock (GRI) Company Profile
Compare GRI vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GRI
Gri Bio Inc
|
2.37 | 3.51M | 0 | -11.96M | -10.19M | -83.74 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Gri Bio Inc Stock (GRI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-09 | 開始されました | H.C. Wainwright | Buy |
Gri Bio Inc (GRI) 最新ニュース
Movement Recap: Is GRI Bio Inc a momentum stock2026 Setups & Weekly Consistent Profit Watchlists - baoquankhu1.vn
If You Invested $1,000 in GRI Bio (GRI) - Stock Titan
Analyst Calls: Is GRI Bio Inc a top pick in the sectorPortfolio Performance Summary & AI Forecasted Stock Moves - baoquankhu1.vn
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Aug Retail: Is HOWL a defensive stockWeekly Stock Report & Smart Money Movement Tracker - baoquankhu1.vn
Aug Setups: Will FWRD outperform tech stocksWeekly Trend Recap & Stock Market Timing Techniques - baoquankhu1.vn
Patterns Watch: What are CLMBs earnings expectationsEarnings Performance Report & Trade Opportunity Analysis - baoquankhu1.vn
Se espera que GRI Bio Inc registre una pérdida de 1,31 dólares por acciónAvance de resultados - TradingView
GRI Bio, Inc. Financial Disclosures & SEC Filings - TradingView
Activity Recap: Can GRI Bio Inc be recession proof2025 Pullback Review & Weekly Setup with High ROI Potential - baoquankhu1.vn
GRI Bio (GRI) Expected to Announce Quarterly Earnings on Friday - Defense World
Update Report: What is OBLGs 5 year growth outlookJuly 2025 Analyst Calls & High Conviction Buy Zone Alerts - baoquankhu1.vn
Short Covering: What makes GRI Bio Inc stock attractive todayWeekly Earnings Recap & High Win Rate Trade Tips - baoquankhu1.vn
GRI PE Ratio & Valuation, Is GRI Overvalued - Intellectia AI
Aug Drivers: Is GRI Bio Inc a top pick in the sector2025 Price Action Summary & Free High Return Stock Watch Alerts - baoquankhu1.vn
GRI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Loss Report: Is GRI Bio Inc stock a smart retirement pickWeekly Gains Report & AI Based Buy and Sell Signals - baoquankhu1.vn
Geopolitics Watch: Can GRI Bio Inc reach all time highs this yearPortfolio Growth Summary & AI Forecast Swing Trade Picks - baoquankhu1.vn
Growth Review: Is GRI Bio Inc stock a smart retirement pick2025 Analyst Calls & Weekly Top Performers Watchlists - baoquankhu1.vn
Is GRI Bio Inc. a momentum stockJuly 2025 Movers & Technical Buy Zone Confirmations - mfd.ru
Market Leaders: What dividend growth rate does CHGG offerJuly 2025 Action & Verified Short-Term Plans - baoquankhu1.vn
Investor Mood: Is GRI Bio Inc stock a smart retirement pickQuarterly Risk Review & Real-Time Volume Surge Alerts - baoquankhu1.vn
GRI Bio CEO, Marc Hertz, Featured in Virtual Investor “What This Means” Segment - The Globe and Mail
GRI Bio CEO, Marc Hertz, Featured in Virtual Investor 'What This Means” Segment - The Manila Times
GRI Bio, Inc. Discusses Positive Phase 2a Data in Idiopathic Pulmonary Fibrosis During Virtual Investor Segment - Quiver Quantitative
Can GRI Bio Inc. stock maintain growth trajectoryProduct Launch & AI Powered Market Entry Strategies - mfd.ru
[SCHEDULE 13G/A] GRI Bio, Inc. Amended Passive Investment Disclosure - Stock Titan
GRI Stock Down on Public Offering Despite Encouraging IPF Study Data - MSN
Is GRI Bio Inc. showing insider buyingJuly 2025 PreEarnings & Daily Technical Stock Forecast Reports - mfd.ru
GRI Bio: Positive phase 2A IPF results and IND plans for lupus program signal strong pipeline momentum - TradingView
GRI Bio: Positive phase 2A IPF data and pipeline progress position GRI Bio for key upcoming milestones - TradingView
Can GRI Bio Inc. reach all time highs this yearStock Surge & Free Growth Oriented Trading Recommendations - mfd.ru
Levels Update: Is now the right time to enter SHF Holdings IncPortfolio Value Report & Verified Momentum Stock Watchlist - baoquankhu1.vn
GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial - Yahoo Finance
GRI Bio reports $8.2 million cash position, extends runway into Q1 2027 - Investing.com Canada
GRI Bio sees cash runway into 1Q27 - TipRanks
GRI Bio raises $14.5 mln to fund operations into Q1 2027 - TradingView
GRI Bio: Strong cash position and positive clinical data support continued pipeline advancement - TradingView
GRI Bio, Inc. Reports Strong Cash Position and Positive Phase 2a Results for GRI-0621 in Pulmonary Fibrosis - Quiver Quantitative
GRI Bio Reiterates Full Year 2025 Financial Results, - GlobeNewswire
GRI Bio (GRI) Price Target Increased by 2,700.00% to 656.88 - Nasdaq
Dip Buying: Is CALX forming bullish engulfing patternsForecast Cut & Free Reliable Trade Execution Plans - baoquankhu1.vn
Aug Summary: What makes GRI Bio Inc stock attractive todayJuly 2025 Rallies & Low Drawdown Trading Techniques - baoquankhu1.vn
Trading Recap: Can OACCU deliver consistent dividendsJuly 2025 Final Week & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Gri Bio Warns of Ongoing Internal Control Weaknesses That Could Threaten Financial Reporting Reliability and Investor Confidence - TipRanks
Rate Cut: Is GRI Bio Inc forming a double bottomQuarterly Portfolio Report & AI Based Trade Execution Alerts - baoquankhu1.vn
Buyback Watch: Is JVSPAC Acquisition Corp Equity Right a momentum stockEarnings Overview Summary & Low Risk Entry Point Tips - baoquankhu1.vn
GRI Bio: 2025 net loss rose to $12M as R&D spending increased; more capital needed for future trials - TradingView
GRI Bio, Inc. SEC 10-K Report - TradingView
GRI Bio Expands At-The-Market Equity Offering Capacity - TipRanks
GRI Bio May Offer Up To $250 Million In SecuritiesSEC Filing - TradingView
Gri Bio Inc (GRI) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):